2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with urothelial carcinoma.
Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with urothelial carcinoma.
Every patient with micro- or macrohematuria has the concern that it could be caused from cancer. However, one of the challenges is determining which patients with hematuria have a significant cancer.
Cxbladder Resolve is a tool that helps better stratify those who are at a higher risk for more significant bladder cancer and get them checked in a more timely manner, explains Raman.
Related Content: